Gothenburg medical-technology group listed on Nasdaq Stockholm that supplies products and genetic testing for in-vitro fertilisation, with about 1,100 employees. In May 2026 its Spanish subsidiary won a Lisbon hospital tender for IVF laboratory reagents, the only Vitrolife award to a Portuguese public buyer on TED.
Vitrolife sells into Portugal from Spain. On 19 May 2026 TED published the award by Unidade Local de Saúde Santa Maria, the Lisbon health unit that runs Hospital de Santa Maria, of a contract for technical laboratory reagents for its human-reproduction unit to Vitrolife Medical Devices Spain, S.L.U., worth €28,682 (TED 341204-2026). The contract is small, but it places Vitrolife products in the IVF laboratory of Portugal’s largest hospital.
The group behind it was founded in Gothenburg in 1994 as Scandinavian IVF Science AB and listed on the Stockholm stock exchange in 2001. It bought the Danish time-lapse embryo-imaging company Unisense FertiliTech in 2014 and the Spanish reproductive-genetics company Igenomix in 2021, which together formed the Vitrolife Group. It now covers culture media, lab equipment and genetic testing for IVF clinics, and says it has about 1,100 employees.
Many Nordic medtech companies reach Portugal through Spanish subsidiaries rather than a Portuguese entity, and public-hospital tenders are how they show up in the data. A foothold in the IVF laboratory of a flagship Lisbon hospital gives Vitrolife a reference for other Portuguese health units.
May 2026 — ULS Santa Maria award for IVF laboratory reagents, €28,682 (TED 341204-2026).
Status: Compiled from public sources · Last verified: · Update this profile
Work at Vitrolife? Send corrections or additions. Every update is checked before it is published; submissions are reviewed within a few working days.
Fractio helps Nordic companies enter the Portuguese market — from market sizing to first sales, hiring, and legal setup.
Talk to Fractio →